CAS 1191900-58-9

Brexpiprazole N-oxide (4-(benzo[b]thiophen-4-yl)-1-(4-((2-oxo-1,2-dihydroquinolin-7-yl)oxy)butyl)piperazine 1-oxide)

CAS: 1191900-58-9

Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi

Formel: C₂₅H₂₇N₃O₃S

Farbe und Form: White Off-White Solid

Molekulargewicht: 449.17731

Ref: 45-1A04590

Brexpiprazole N1-Oxide

CAS: 1191900-58-9

Formel: C₂₅H₂₇N₃O₃S

Farbe und Form: White To Off-White Solid

Molekulargewicht: 449.57

Ref: 4Z-B-115004

Brexpiprazole-d8 N-Oxide

CAS: 1191900-58-9

Formel: C₂₅H₁₉D₈N₃O₃S

Molekulargewicht: 457.62

Ref: 4Z-B-115029

Brexpiprazole N-Oxide

Kontrolliertes Produkt

CAS: 1191900-58-9

Stability Not Stable in DMSO
Applications Brexpiprazole N-Oxide is an impurity and potential metabolite of Brexpiprazole (B677385), a drug candidate useful in treatment and prevention of mental disorders including CNS disorders.
References Yamashita, H., et al.: PCT Int. Appl., WO 2006112464 A1 20061026 (2006);

Formel: C₂₅H₂₇N₃O₃S

Farbe und Form: Neat

Molekulargewicht: 449.57

Ref: TR-B677425

Brexpiprazole N-Oxide

CAS: 1191900-58-9

Formel: C₂₅H₂₇N₃O₃S

Molekulargewicht: 449.57

Ref: ST-EA-CP-B15004

Brexpiprazole impurity 3

CAS: 1191900-58-9

Brexpiprazole impurity 3 is a drug product that has been custom synthesized for research purposes. The purity of this product is high and it has been analyzed using analytical methods. This product can be used to study the metabolism of brexpiprazole, which is an atypical antipsychotic medication. Brexpiprazole impurity 3 also has pharmacopoeia standards, which can be used to develop new drugs or as a quality control standard in research and development.

Formel: C₂₅H₂₇N₃O₃S

Reinheit: Min. 95%

Molekulargewicht: 449.57 g/mol

Ref: 3D-IB106464